Taxane silicate prodrugs and nanoparticles
US9375484B2 · kind B2 · utility
0Cited by
4References
35Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 31, 2012 |
| Grant date | Jun 28, 2016 |
| Priority date | — |
| Expiry date | May 31, 2032 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/19
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides silicate prodrugs comprising a therapeutic agent linked to one or more groups of formula (I): —Si(OR)3 (I); wherein each R independently has any of the values defined herein, as well as nanoparticles comprising such compounds.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.